PDP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.339000E-01
Normal-vs-Stage2
8.666000E-01
Normal-vs-Stage3
4.676800E-01
Normal-vs-Stage4
8.122200E-01
Stage1-vs-Stage2
1.585760E-01
Stage1-vs-Stage3
6.605600E-01
Stage1-vs-Stage4
2.100200E-01
Stage2-vs-Stage3
4.725400E-01
Stage2-vs-Stage4
5.278200E-01
Stage3-vs-Stage4
4.620400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.272200E-01
Normal-vs-AfricanAmerican
9.222400E-01
Normal-vs-Asian
9.939000E-01
Caucasian-vs-AfricanAmerican
7.211000E-01
Caucasian-vs-Asian
5.315800E-01
AfricanAmerican-vs-Asian
9.278600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.624200E-01
Normal-vs-Female
8.360200E-01
Male-vs-Female
5.830000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.997600E-01
Normal-vs-Age(41-60Yrs)
8.003600E-01
Normal-vs-Age(61-80Yrs)
6.416600E-01
Normal-vs-Age(81-100Yrs)
3.392000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.580000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.676800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.082000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.205990E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.899800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.406600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.454800E-01
Normal-vs-Daily Drinker
6.506800E-01
Normal-vs-Weekly Drinker
5.594800E-01
Normal-vs-Occasional Drinker
8.443200E-01
Normal-vs-Social Drinker
9.534000E-01
Non Drinker-vs-Daily Drinker
7.677600E-01
Non Drinker-vs-Weekly Drinker
8.729200E-01
Non Drinker-vs-Occasional Drinker
2.178200E-01
Non Drinker-vs-Social Drinker
5.325200E-01
Daily Drinker-vs-Weekly Drinker
9.087800E-01
Daily Drinker-vs-Occasional Drinker
2.311400E-01
Daily Drinker-vs-Social Drinker
4.825000E-01
Weekly Drinker-vs-Occasional Drinker
2.703200E-01
Weekly Drinker-vs-Social Drinker
5.253800E-01
Occasional Drinker-vs-Social Drinker
6.585000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.131600E-01
Normal-vs-Grade 2
1.318780E-01
Normal-vs-Grade 3
1.368780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.002810E-01
Grade 1-vs-Grade 3
1.466310E-02
Grade 1-vs-Grade 4
5.131600E-01
Grade 2-vs-Grade 3
1.462440E-01
Grade 2-vs-Grade 4
1.318780E-01
Grade 3-vs-Grade 4
1.368780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.593800E-01
Normal-vs-NonDiabetic
7.940000E-01
Diabetic-vs-NonDiabetic
3.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.970200E-01
Normal-vs-NoPancreatitis
7.387200E-01
Pancreatitis-vs-NoPancreatitis
5.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.293600E-01
Normal-vs-N1
8.425400E-01
N0-vs-N1
5.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.025800E-01
Normal-vs-TP53-NonMutant
6.148200E-01
TP53-Mutant-vs-TP53-NonMutant
7.166400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
